Josef Mintz

Josef Mintz

Blank Rome LLP

Contact
View Bio
RSS

Latest Posts › Reimbursements

Share:

Impact of Recent CMS Rule on Site Neutrality and 340B Programs—Implications for Oncology Services

Overview - The Centers for Medicare & Medicaid Services (“CMS”) has finalized and proposed several significant changes affecting both site neutrality in Medicare payments and the 340B Drug Pricing Program. These changes...more

7/24/2025  /  Drug Pricing , Health Care Providers , Hospitals , Medicare , Pharmaceutical Industry , Regulatory Requirements , Reimbursements
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide